NCT04849585

Brief Summary

To evaluate the psychological, physical, social, professional and family impact of a hospitalization in intensive care for a covid 19 by analysis of the verbatim during a semi-structured interview.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 23, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 19, 2021

Completed
1.1 years until next milestone

Study Start

First participant enrolled

June 1, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2023

Completed
Last Updated

May 10, 2022

Status Verified

May 1, 2022

Enrollment Period

6 months

First QC Date

February 23, 2021

Last Update Submit

May 9, 2022

Conditions

Covid19

Outcome Measures

Primary Outcomes (2)

  • Psychological impact of hospitalization in intensive care for a covid 19.

    Frequency of recurring nightmares, irritability and anxious patient

    At day 1

  • Physical impact of hospitalization in intensive care for a covid 19.

    Frequency of Handicap and resumption of professional and personal activities

    At day 1

Interventions

semi-directed entretienOTHER

semi-directed entretien

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients hospitalized in intensive care at CH Dron for a COVID 19

You may qualify if:

  • All patients hospitalized in intensive care at CH Dron for a COVID 19 who have given their agreement during their follow-up consultation

You may not qualify if:

  • Minor patient
  • Patient does not speak French
  • Refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CH Tourcoing

Tourcoing, France

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Pauline THILL, MD

    CH TOURCOING

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Pauline THILL, MD

CONTACT

0320694949pthill@ch-tourcoing.fr

Solange TREHOUX, PhD

CONTACT

0320694280strehoux@ch-tourcoing.fr

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 23, 2021

First Posted

April 19, 2021

Study Start

June 1, 2022

Primary Completion

December 1, 2022

Study Completion

February 1, 2023

Last Updated

May 10, 2022

Record last verified: 2022-05

Locations

FR(1)